Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs

Abstract Background The amount of surfactant deposited in the lungs and its overall pulmonary distribution determine the therapeutic outcome of surfactant replacement therapy. Most of the currently available methods to determine the intrapulmonary distribution of surfactant are time-consuming and re...

Full description

Bibliographic Details
Main Authors: Riccardo Zecchi, Pietro Franceschi, Laura Tigli, Francesca Ricci, Francesca Boscaro, Barbara Pioselli, Valentina Mileo, Xabier Murgia, Federico Bianco, Fabrizio Salomone, Augusto F. Schmidt, Noah H. Hillman, Matthew W. Kemp, Alan H. Jobe
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Respiratory Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12931-019-1144-5
_version_ 1818511263982944256
author Riccardo Zecchi
Pietro Franceschi
Laura Tigli
Francesca Ricci
Francesca Boscaro
Barbara Pioselli
Valentina Mileo
Xabier Murgia
Federico Bianco
Fabrizio Salomone
Augusto F. Schmidt
Noah H. Hillman
Matthew W. Kemp
Alan H. Jobe
author_facet Riccardo Zecchi
Pietro Franceschi
Laura Tigli
Francesca Ricci
Francesca Boscaro
Barbara Pioselli
Valentina Mileo
Xabier Murgia
Federico Bianco
Fabrizio Salomone
Augusto F. Schmidt
Noah H. Hillman
Matthew W. Kemp
Alan H. Jobe
author_sort Riccardo Zecchi
collection DOAJ
description Abstract Background The amount of surfactant deposited in the lungs and its overall pulmonary distribution determine the therapeutic outcome of surfactant replacement therapy. Most of the currently available methods to determine the intrapulmonary distribution of surfactant are time-consuming and require surfactant labelling. Our aim was to assess the potential of Mass Spectrometry Imaging (MSI) as a label-free technique to qualitatively and quantitatively evaluate the distribution of surfactant to the premature lamb. Methods Twelve preterm lambs (gestational age 126-127d, term ~150d) were allocated in two experimental groups. Seven lambs were treated with an intratracheal bolus of the synthetic surfactant CHF5633 (200 mg/kg) and 5 lambs were managed with mechanical ventilation for 120 min, as controls. The right lung lobes of all lambs were gradually frozen while inflated to 20 cmH2O pressure for lung cryo-sections for MSI analysis. The intensity signals of SP-C analog and SP-B analog, the two synthetic peptides contained in the CHF5633 surfactant, were used to locate, map and quantify the intrapulmonary exogenous surfactant. Results Surfactant treatment was associated with a significant improvement of the mean arterial oxygenation and lung compliance (p < 0.05). Nevertheless, the physiological response to surfactant treatment was not uniform across all animals. SP-C analog and SP-B analog were successfully imaged and quantified by means of MSI in the peripheral lungs of all surfactant-treated animals. The intensity of the signal was remarkably low in untreated lambs, corresponding to background noise. The signal intensity of SP-B analog in each surfactant-treated animal, which represents the surfactant distributed to the peripheral right lung, correlated well with the physiologic response as assessed by the area under the curves of the individual arterial partial oxygen pressure and dynamic lung compliance curves of the lambs. Conclusions Applying MSI, we were able to detect, locate and quantify the amount of exogenous surfactant distributed to the lower right lung of surfactant-treated lambs. The distribution pattern of SP-B analog correlated well with the pulmonary physiological outcomes of the animals. MSI is a valuable label-free technique which is able to simultaneously evaluate qualitative and quantitative drug distribution in the lung.
first_indexed 2024-12-10T23:30:59Z
format Article
id doaj.art-979ca60013de43c6880ec022810ad441
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-10T23:30:59Z
publishDate 2019-08-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-979ca60013de43c6880ec022810ad4412022-12-22T01:29:23ZengBMCRespiratory Research1465-993X2019-08-0120111210.1186/s12931-019-1144-5Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambsRiccardo Zecchi0Pietro Franceschi1Laura Tigli2Francesca Ricci3Francesca Boscaro4Barbara Pioselli5Valentina Mileo6Xabier Murgia7Federico Bianco8Fabrizio Salomone9Augusto F. Schmidt10Noah H. Hillman11Matthew W. Kemp12Alan H. Jobe13Mass Spectrometry Service Center (CISM), University of FlorenceComputational Biology, Research and Innovation Centre, Fondazione Edmund MachPreclinical R&D, Chiesi FarmaceuticiPreclinical R&D, Chiesi FarmaceuticiMass Spectrometry Service Center (CISM), University of FlorencePreclinical R&D, Chiesi FarmaceuticiPreclinical R&D, Chiesi FarmaceuticiScientific ConsultancyPreclinical R&D, Chiesi FarmaceuticiPreclinical R&D, Chiesi FarmaceuticiDivision of Neonatology and Pulmonary Biology, Cincinnati Children’s HospitalDivision of Neonatology, Cardinal Glennon Children’s Hospital, Saint Louis UniversityDivision of Obstetrics and Gynecology, University of Western AustraliaDivision of Neonatology, Cardinal Glennon Children’s Hospital, Saint Louis UniversityAbstract Background The amount of surfactant deposited in the lungs and its overall pulmonary distribution determine the therapeutic outcome of surfactant replacement therapy. Most of the currently available methods to determine the intrapulmonary distribution of surfactant are time-consuming and require surfactant labelling. Our aim was to assess the potential of Mass Spectrometry Imaging (MSI) as a label-free technique to qualitatively and quantitatively evaluate the distribution of surfactant to the premature lamb. Methods Twelve preterm lambs (gestational age 126-127d, term ~150d) were allocated in two experimental groups. Seven lambs were treated with an intratracheal bolus of the synthetic surfactant CHF5633 (200 mg/kg) and 5 lambs were managed with mechanical ventilation for 120 min, as controls. The right lung lobes of all lambs were gradually frozen while inflated to 20 cmH2O pressure for lung cryo-sections for MSI analysis. The intensity signals of SP-C analog and SP-B analog, the two synthetic peptides contained in the CHF5633 surfactant, were used to locate, map and quantify the intrapulmonary exogenous surfactant. Results Surfactant treatment was associated with a significant improvement of the mean arterial oxygenation and lung compliance (p < 0.05). Nevertheless, the physiological response to surfactant treatment was not uniform across all animals. SP-C analog and SP-B analog were successfully imaged and quantified by means of MSI in the peripheral lungs of all surfactant-treated animals. The intensity of the signal was remarkably low in untreated lambs, corresponding to background noise. The signal intensity of SP-B analog in each surfactant-treated animal, which represents the surfactant distributed to the peripheral right lung, correlated well with the physiologic response as assessed by the area under the curves of the individual arterial partial oxygen pressure and dynamic lung compliance curves of the lambs. Conclusions Applying MSI, we were able to detect, locate and quantify the amount of exogenous surfactant distributed to the lower right lung of surfactant-treated lambs. The distribution pattern of SP-B analog correlated well with the pulmonary physiological outcomes of the animals. MSI is a valuable label-free technique which is able to simultaneously evaluate qualitative and quantitative drug distribution in the lung.http://link.springer.com/article/10.1186/s12931-019-1144-5SurfactantCHF5633Mass spectrometry imagingRespiratory distress syndromePremature lambs
spellingShingle Riccardo Zecchi
Pietro Franceschi
Laura Tigli
Francesca Ricci
Francesca Boscaro
Barbara Pioselli
Valentina Mileo
Xabier Murgia
Federico Bianco
Fabrizio Salomone
Augusto F. Schmidt
Noah H. Hillman
Matthew W. Kemp
Alan H. Jobe
Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
Respiratory Research
Surfactant
CHF5633
Mass spectrometry imaging
Respiratory distress syndrome
Premature lambs
title Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
title_full Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
title_fullStr Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
title_full_unstemmed Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
title_short Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
title_sort mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs
topic Surfactant
CHF5633
Mass spectrometry imaging
Respiratory distress syndrome
Premature lambs
url http://link.springer.com/article/10.1186/s12931-019-1144-5
work_keys_str_mv AT riccardozecchi massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT pietrofranceschi massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT lauratigli massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT francescaricci massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT francescaboscaro massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT barbarapioselli massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT valentinamileo massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT xabiermurgia massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT federicobianco massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT fabriziosalomone massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT augustofschmidt massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT noahhhillman massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT matthewwkemp massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs
AT alanhjobe massspectrometryimagingasatoolforevaluatingthepulmonarydistributionofexogenoussurfactantinprematurelambs